Related Experiment Videos
'Double marker' lymphocytes in patients receiving tetracycline
Clinical and Experimental Immunology
|October 1, 1978
Abstract:
When T and B cell counts, using sheep cell rosettes and surface immunoglobulin as markers, are done on the lymphocytes of individuals who are receiving tetracycline, unusually high numbers of 'double marker' cells are regularly found.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Fitting Emax models to clinical trial dose-response data when the high dose asymptote is ill defined.
Pharmaceutical statistics·2014
Loss of social status: preliminary evaluation of a novel animal model of depression.
Journal of psychopharmacology (Oxford, England)·2012
Selinexor potentiates NK cell activation against multiple myeloma.
Clinical and experimental immunology·2026
Management of hereditary angioedema in the UK: a comparison with international guidelines.
Clinical and experimental immunology·2026
Epitope-Specific Thyroid Peroxidase Antibodies Reveal Functional Heterogeneity Within a Patient-Derived Monoclonal Repertoire.
Clinical and experimental immunology·2026
The C-terminal cysteines in zinc transporter 8 (ZnT8) form an independent epitope for autoantibody binding in newly diagnosed type 1 diabetes.
Clinical and experimental immunology·2026
Prospective association between leukocyte telomere length and mortality: findings from the Black Women's Experiences Living with Lupus (BeWELL) Study.
Clinical and experimental immunology·2026
Small extracellular vesicles from the plasma of head and neck cancer patients induce dysfunctional T cell phenotypes.
British journal of cancer·2026
Individual and systems level factors associated with odds of orchiectomy in testicular torsion in New York State.
Journal of pediatric urology·2026
USP11 exacerbates intestinal I/R injury by driving NCOA4-mediated ferritinophagy and ferroptosis via Beclin-1 deubiquitination.
International immunopharmacology·2026